GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **526 - 550** of **4050** in total

« First

‹ Prev

…

18

19

20

21

22

23

24

25

26

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom ▲	GlyTouCan ID	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	24	mild	G90223GH	229
IgG	Patient 2	24	mild	G90562PB	35
IgG	Patient 2	24	mild	G91237TK	50
IgG	Patient 2	24	mild	G91537AT	957
IgG	Patient 2	24	mild	G92022ML	150
IgG	Patient 2	24	mild	G92823JK	32
IgG	Patient 2	24	mild	G93351GM	4880
IgG	Patient 2	24	mild	G94435QH	115
IgG	Patient 2	24	mild	G94576MN	9703
IgG	Patient 2	24	mild	G96557TJ	457
IgG	Patient 2	24	mild	G96865DJ	37
IgG	Patient 2	24	mild	G96881BQ	29
IgG	Patient 2	24	mild	G98068PA	38
IgG	Patient 2	24	mild	G98240FC	262
IgG	Patient 2	24	mild	G99603GB	14686
IgM	Patient 2	15	mild	G00048MO	58
IgM	Patient 2	15	mild	G00051MO	41
IgM	Patient 2	15	mild	G00052MO	62
IgM	Patient 2	15	mild	G00053MO	51
IgM	Patient 2	15	mild	G00054MO	45
IgM	Patient 2	15	mild	G00057MO	943
IgM	Patient 2	15	mild	G00065MO	75
IgM	Patient 2	15	mild	G00066MO	2083
IgM	Patient 2	15	mild	G00068MO	81
IgM	Patient 2	15	mild	G02557XE	42